Marc Theoret

Associate Director of Immunotherapeutics, OHOP, OND, CDER
Dr. Theoret is a medical oncologist and the Associate Director of Immunotherapeutics in the Office of Hematology and Oncology Products, CDER, FDA. In his role as Associate Director, Dr. Theoret is leading initiatives in immuno-oncology product development—regulatory, scientific, and policy efforts. His regulatory research interests include evaluation of novel endpoints for development of cancer immunotherapies and novel trial designs to expedite drug development in oncology.

My Speakers Sessions

Wednesday, June 21

10:30am CDT